Post by iOMEDICO
1,119 followers
+++ ๐ถ๐ข๐ ๐๐๐๐๐ข ๐ฎ๐ ๐๐ง๐ฆ๐ฆ ๐ฎ๐ฌ๐ฎ๐ฒ: ๐ฅ๐ช๐ ๐๐ผ ๐ข๐ฝ๐๐ถ๐บ๐ถ๐๐ฒ ๐๐ฟ๐๐ด ๐๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐ ๐ถ๐ป ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ +++ ย Today, Michael Prรถschel presented at the #CTSS2026 insights into the use of #RWD for Optimizing Drug Development in #Oncology. Key topics were: ย - Improved Covariate Adjustment based on RWD - Using External Control Arms (#ECA) - The regulatory landscape for RWD - RWD for the Joint Clinical Assessment (#JCA) - Importance of RWD being Fit-for-Purpose ย At iOMEDICO we are 100% dedicated to Oncology and Hematology. With multiple regulatory grade clinical registries we help accelerate clinical development and market access. ย #RealWorldData #realworldevidence #tumorregistry #ExternalControlArms #ClinicalResearch #iOMEDICO #CRO